MEMBRANEBLUE Drug Patent Profile
✉ Email this page to a colleague
When do Membraneblue patents expire, and when can generic versions of Membraneblue launch?
Membraneblue is a drug marketed by Dorc and is included in one NDA.
The generic ingredient in MEMBRANEBLUE is trypan blue. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trypan blue profile page.
Summary for MEMBRANEBLUE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in MEMBRANEBLUE? | MEMBRANEBLUE excipients list |
| DailyMed Link: | MEMBRANEBLUE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MEMBRANEBLUE
US Patents and Regulatory Information for MEMBRANEBLUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dorc | MEMBRANEBLUE | trypan blue | SOLUTION;OPHTHALMIC | 022278-001 | Feb 20, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MEMBRANEBLUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dorc | MEMBRANEBLUE | trypan blue | SOLUTION;OPHTHALMIC | 022278-001 | Feb 20, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
| Dorc | MEMBRANEBLUE | trypan blue | SOLUTION;OPHTHALMIC | 022278-001 | Feb 20, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MEMBRANEBLUE
See the table below for patents covering MEMBRANEBLUE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Spain | 2197639 | ⤷ Try a Trial | |
| Austria | 232400 | ⤷ Try a Trial | |
| European Patent Office | 1075284 | EMPLOI DE COLORANT VITAL POUR FACILITER DES INTERVENTIONS EN CHIRURGIE VITREO-RETINIENNE (THE USE OF A VITAL DYE FOR FACILITATING SURGICAL PROCEDURES FOR VITREO-RETINAL SURGERY) | ⤷ Try a Trial |
| Poland | 343924 | ⤷ Try a Trial | |
| European Patent Office | 1075285 | EMPLOI DE COLORANT VITAL POUR FACILITER DES INTERVENTIONS CHIRURGICALES D'EXTRACTION DE LA CATARACTE (THE USE OF A VITAL DYE FOR FACILITATING SURGICAL PROCEDURES FOR CATARACT EXTRACTION) | ⤷ Try a Trial |
| Japan | 3953322 | ⤷ Try a Trial | |
| World Intellectual Property Organization (WIPO) | 9958159 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
NCE-1 Patent Challenge Dates 2023 - 2024
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
